# FEBUXOSTAT
> **ANDA206266** · Abbreviated New Drug Application (Generic) · Sponsor: PRINSTON INC · Approved 2022-03-28
## Drug
- **FDA Application Number:** ANDA206266
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** FEBUXOSTAT
- **Generic name:** FEBUXOSTAT
- **Active ingredients:** FEBUXOSTAT
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** PRINSTON INC
- **Manufacturer:** Solco Healthcare US LLC
- **First approval:** 2022-03-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206266)
---
*AI Analytics · CC0 1.0*